KCNJ5 and Cowden syndrome 1: Recently, a child with mild, cyclical CS due to PBAMH, who carries a novel germline pathogenic variant in KCNJ5, was treated at 4 years 9 months with very low doses of ketoconazole (300 mg/day), increased to 400 mg/day at 8 years.